State of Illinois
91st General Assembly
Legislation

   [ Search ]   [ Legislation ]
[ Home ]   [ Back ]   [ Bottom ]


[ Introduced ][ House Amendment 001 ]

91_HB1801eng

 
HB1801 Engrossed                               LRB9105700ACtm

 1        AN ACT to amend the Pharmacy  Practice  Act  of  1987  by
 2    changing Section 3.

 3        Be  it  enacted  by  the People of the State of Illinois,
 4    represented in the General Assembly:

 5        Section 5.  The Pharmacy Practice Act of 1987 is  amended
 6    by changing Section 3 as follows:

 7        (225 ILCS 85/3) (from Ch. 111, par. 4123)
 8        Sec.  3.  Definitions.   For the purposes purpose of this
 9    Act, except where otherwise limited therein:
10        (a)  "Pharmacy" or "drugstore" means and  includes  every
11    store,  shop,  pharmacy  department,  or  other  place  where
12    pharmaceutical  care  is  provided  by a pharmacist (1) where
13    drugs, medicines, or poisons are dispensed, sold  or  offered
14    for  sale  at retail, or displayed for sale at retail; or (2)
15    where prescriptions of physicians,  dentists,  veterinarians,
16    podiatrists,   or   therapeutically  certified  optometrists,
17    within the limits of their licenses, are compounded,  filled,
18    or  dispensed;  or  (3) which has upon it or displayed within
19    it, or affixed to or used  in  connection  with  it,  a  sign
20    bearing   the   word   or   words  "Pharmacist",  "Druggist",
21    "Pharmacy", "Pharmaceutical Care", "Apothecary", "Drugstore",
22    "Medicine Store", "Prescriptions", "Drugs",  "Medicines",  or
23    any  word  or  words of similar or like import, either in the
24    English language or any other  language;  or  (4)  where  the
25    characteristic  prescription  sign  (Rx) or similar design is
26    exhibited; or (5) any store, or shop,  or  other  place  with
27    respect  to  which  any of the above words, objects, signs or
28    designs are used in any advertisement.
29        (b)  "Drugs" means and includes (l)  articles  recognized
30    in   the   official   United   States  Pharmacopoeia/National
31    Formulary (USP/NF),  or  any  supplement  thereto  and  being
 
HB1801 Engrossed            -2-                LRB9105700ACtm
 1    intended  for  and  having  for their main use the diagnosis,
 2    cure, mitigation, treatment or prevention of disease  in  man
 3    or  other  animals, as approved by the United States Food and
 4    Drug Administration, but does not include  devices  or  their
 5    components, parts, or accessories; and (2) all other articles
 6    intended  for  and  having  for their main use the diagnosis,
 7    cure, mitigation, treatment or prevention of disease  in  man
 8    or  other  animals, as approved by the United States Food and
 9    Drug Administration, but does not include  devices  or  their
10    components,  parts,  or  accessories; and (3) articles (other
11    than food) having for their main use and intended  to  affect
12    the  structure  or  any  function of the body of man or other
13    animals; and (4) articles  having  for  their  main  use  and
14    intended  for use as a component or any articles specified in
15    clause (l), (2) or (3); but does not include devices or their
16    components, parts or accessories.
17        (c)  "Medicines" means and includes  all  drugs  intended
18    for  human  or  veterinary  use approved by the United States
19    Food and Drug Administration.
20        (d)  "Practice  of  pharmacy"  means  the  provision   of
21    pharmaceutical   care   to  patients  as  determined  by  the
22    pharmacist's professional judgment in  the  following  areas,
23    which  may  include  but  are  not  limited  to  (1)  patient
24    counseling,   (2)   interpretation   and   assisting  in  the
25    monitoring of  appropriate  drug  use  and  prospective  drug
26    utilization   review,   (3)   providing  information  on  the
27    therapeutic  values,  reactions,  drug   interactions,   side
28    effects,  uses, selection of medications and medical devices,
29    and outcome  of  drug  therapy,  (4)  participation  in  drug
30    selection,   drug   monitoring,   drug   utilization  review,
31    evaluation, administration,  interpretation,  application  of
32    pharmacokinetic  and  laboratory  data  to  design  safe  and
33    effective  drug  regimens,  (5)  drug  research (clinical and
34    scientific), and (6) compounding and dispensing of drugs  and
 
HB1801 Engrossed            -3-                LRB9105700ACtm
 1    medical devices.
 2        (e)  "Prescription" means and includes any written, oral,
 3    facsimile,  or  electronically transmitted order for drugs or
 4    medical devices, issued by a physician licensed  to  practice
 5    medicine  in  all  its  branches,  dentist,  veterinarian, or
 6    podiatrist,  or therapeutically certified optometrist, within
 7    the limits of their licenses, by  a  physician  assistant  in
 8    accordance  with  subsection  (f)  of  Section  4,  or  by an
 9    advanced practice nurse in accordance with subsection (g)  of
10    Section 4, containing the following: (l) name of the patient;
11    (2)  date when prescription was issued; (3) name and strength
12    of drug or description of the medical device prescribed;  and
13    (4)  quantity, (5) directions for use, (6) prescriber's name,
14    address and signature, and (7) DEA number where required, for
15    controlled substances. DEA numbers shall not be  required  on
16    inpatient drug orders.
17        (f)  "Person"   means  and  includes  a  natural  person,
18    copartnership, association, corporation,  government  entity,
19    or any other legal entity.
20        (g)  "Department"  means  the  Department of Professional
21    Regulation.
22        (h)  "Board of Pharmacy" or "Board" means the State Board
23    of Pharmacy of the Department of Professional Regulation.
24        (i)  "Director"  means  the  Director   of   Professional
25    Regulation.
26        (j)  "Drug product selection" means the interchange for a
27    prescribed  pharmaceutical product in accordance with Section
28    25 of this Act and Section 3.14 of the  Illinois  Food,  Drug
29    and Cosmetic Act.
30        (k)  "Inpatient  drug  order" means an order issued by an
31    authorized prescriber for a resident or patient of a facility
32    licensed under the Nursing Home  Care  Act  or  the  Hospital
33    Licensing  Act,  or  "An  Act in relation to the founding and
34    operation of the University  of  Illinois  Hospital  and  the
 
HB1801 Engrossed            -4-                LRB9105700ACtm
 1    conduct  of  University  of  Illinois  health care programs",
 2    approved July 3, 1931, as amended, or  a  facility  which  is
 3    operated by the Department of Human Services (as successor to
 4    the   Department   of   Mental   Health   and   Developmental
 5    Disabilities) or the Department of Corrections.
 6        (k-5)  "Pharmacist"   means   an   individual   currently
 7    licensed by this State to engage in the practice of pharmacy.
 8        (l)  "Pharmacist in charge" means the licensed pharmacist
 9    whose  name  appears on a pharmacy license who is responsible
10    for all aspects of the operation related to the  practice  of
11    pharmacy.
12        (m)  "Dispense"  means  the delivery of drugs and medical
13    devices, in accordance with applicable State and federal laws
14    and  regulations,   to   the   patient   or   the   patient's
15    representative   authorized   to   receive   these  products,
16    including the compounding, packaging, and labeling  necessary
17    for delivery, and any recommending or advising concerning the
18    contents  and therapeutic values and uses thereof. "Dispense"
19    does not mean  the  physical  delivery  to  a  patient  or  a
20    patient's  representative  in  a  home  or  institution  by a
21    designee of a pharmacist or by  common  carrier.   "Dispense"
22    also does not mean the physical delivery of a drug or medical
23    device   to  a  patient  or  patient's  representative  by  a
24    pharmacist's designee within a pharmacy  or  drugstore  while
25    the pharmacist is on duty and the pharmacy is open.
26        (n)  "Mail-order  pharmacy"  means  a  pharmacy  that  is
27    located in a state of the United States, other than Illinois,
28    that  delivers,  dispenses or distributes, through the United
29    States Postal Service or other common  carrier,  to  Illinois
30    residents, any substance which requires a prescription.
31        (o)  "Compounding"   means   the   preparation,   mixing,
32    assembling,  packaging,  or  labeling  of  a  drug or medical
33    device: (1) as the result of  a  practitioner's  prescription
34    drug  order  or  initiative  that  is dispensed pursuant to a
 
HB1801 Engrossed            -5-                LRB9105700ACtm
 1    prescription in the course of professional practice;  or  (2)
 2    for  the  purpose  of, or incident to, research, teaching, or
 3    chemical analysis; or (3)  in  anticipation  of  prescription
 4    drug  orders based on routine, regularly observed prescribing
 5    patterns.
 6        (p)  "Confidential   information"   means    information,
 7    maintained  by  the  pharmacist  in  the  patient's  records,
 8    released  only (i) to the patient or, as the patient directs,
 9    to other practitioners and other pharmacists or (ii)  to  any
10    other person authorized by law to receive the information.
11        (q)  "Prospective   drug  review"  or  "drug  utilization
12    evaluation" means a  screening  for  potential  drug  therapy
13    problems   due   to   therapeutic  duplication,  drug-disease
14    contraindications, drug-drug interactions (including  serious
15    interactions with nonprescription or over-the-counter drugs),
16    drug-food  interactions, incorrect drug dosage or duration of
17    drug treatment, drug-allergy interactions, and clinical abuse
18    or misuse.
19        (r)  "Patient counseling" means the communication between
20    a  pharmacist  or  a  student  pharmacist  under  the  direct
21    supervision of a pharmacist and a patient  or  the  patient's
22    representative  about  the patient's medication or device for
23    the  purpose  of  optimizing  proper  use   of   prescription
24    medications   or  devices.   The  offer  to  counsel  by  the
25    pharmacist  or  the  pharmacist's  designee,  and  subsequent
26    patient counseling by the pharmacist or  student  pharmacist,
27    shall  be  made  in  a  face-to-face  communication  with the
28    patient  or   patient's   representative   unless,   in   the
29    professional  judgment  of  the  pharmacist,  a  face-to-face
30    communication  is  deemed  inappropriate  or unnecessary.  In
31    that instance, the offer to counsel or patient counseling may
32    be made in a written communication, by  telephone,  or  in  a
33    manner determined by the pharmacist to be appropriate.
34        (s)  "Patient  profiles" or "patient drug therapy record"
 
HB1801 Engrossed            -6-                LRB9105700ACtm
 1    means the obtaining, recording, and  maintenance  of  patient
 2    prescription and personal information.
 3        (t)  "Pharmaceutical  care"  includes, but is not limited
 4    to, the act of monitoring drug use  and  other  patient  care
 5    services  intended  to  achieve  outcomes  that  improve  the
 6    patient's  quality  of life but shall not include the sale of
 7    over-the-counter drugs by a seller of goods and services  who
 8    does not dispense prescription drugs.
 9        (u)  "Medical  device"  means  an  instrument, apparatus,
10    implement, machine, contrivance, implant, in  vitro  reagent,
11    or  other similar or related article, including any component
12    part or accessory, required under federal  law  to  bear  the
13    label  "Caution: Federal law requires dispensing by or on the
14    order of a physician". A seller of goods  and  services  who,
15    only  for  the  purpose  of  retail  sales, compounds, sells,
16    rents, or  leases  medical  devices  shall  not,  by  reasons
17    thereof, be required to be a licensed pharmacy.
18    (Source: P.A.  89-202,  eff.  7-21-95;  89-507,  eff. 7-1-97;
19    90-116, eff. 7-14-97;  90-253,  eff.  7-29-97;  90-655,  eff.
20    7-30-98; 90-742, eff. 8-13-98.)

[ Top ]